1. Home
  2. IMRN vs REBN Comparison

IMRN vs REBN Comparison

Compare IMRN & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • REBN
  • Stock Information
  • Founded
  • IMRN 1994
  • REBN 2015
  • Country
  • IMRN Australia
  • REBN United States
  • Employees
  • IMRN N/A
  • REBN N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • IMRN Health Care
  • REBN Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • REBN Nasdaq
  • Market Cap
  • IMRN 9.2M
  • REBN 13.5M
  • IPO Year
  • IMRN N/A
  • REBN 2022
  • Fundamental
  • Price
  • IMRN N/A
  • REBN $2.79
  • Analyst Decision
  • IMRN Strong Buy
  • REBN
  • Analyst Count
  • IMRN 1
  • REBN 0
  • Target Price
  • IMRN $5.00
  • REBN N/A
  • AVG Volume (30 Days)
  • IMRN 24.6K
  • REBN 60.7K
  • Earning Date
  • IMRN 07-15-2025
  • REBN 08-18-2025
  • Dividend Yield
  • IMRN N/A
  • REBN N/A
  • EPS Growth
  • IMRN N/A
  • REBN N/A
  • EPS
  • IMRN N/A
  • REBN N/A
  • Revenue
  • IMRN $4,048,286.00
  • REBN $6,103,732.00
  • Revenue This Year
  • IMRN N/A
  • REBN $335.98
  • Revenue Next Year
  • IMRN N/A
  • REBN N/A
  • P/E Ratio
  • IMRN N/A
  • REBN N/A
  • Revenue Growth
  • IMRN 82.90
  • REBN 3.38
  • 52 Week Low
  • IMRN $1.50
  • REBN $1.03
  • 52 Week High
  • IMRN $2.87
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 49.46
  • REBN 55.87
  • Support Level
  • IMRN $1.56
  • REBN $2.37
  • Resistance Level
  • IMRN $1.96
  • REBN $3.00
  • Average True Range (ATR)
  • IMRN 0.11
  • REBN 0.17
  • MACD
  • IMRN -0.01
  • REBN 0.04
  • Stochastic Oscillator
  • IMRN 53.75
  • REBN 61.41

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: